NADPH inhibits [2Fe-2S] cluster protein transfer from diabetes drug target MitoNEET to an Apo-acceptor protein

Journal of Biological Chemistry

Volumn 287, Issue 15, 2012, Pages 11649-11655

  Zuris, John A ^a   Ali, Syed S ^a   Yeh, Howard ^a   Nguyen, Tung A ^a   Nechushtai, Rachel ^b   Paddock, Mark L ^a   Jennings, Patricia A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR FUNCTION; CLUSTER TRANSFER; CYTOSOLIC; DRUG TARGETS; ELECTRON TRANSFER; INHIBITION CONSTANTS; OXIDATIVE DAMAGE; PHYSIOLOGICAL CONDITION; PROTEIN TRANSFER; THIAZOLIDINEDIONES;

BIOCHEMISTRY; BIOLOGY;

PROTEINS;

APO ACCEPTOR PROTEIN; APO FERREDOXIN; FERREDOXIN; IRON SULFUR PROTEIN; MITONEET PROTEIN; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ARTICLE; BINDING KINETICS; CONTROLLED STUDY; OXIDATION REDUCTION POTENTIAL; PH; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

AMINO ACID MOTIFS; APOPROTEINS; BINDING SITES; BINDING, COMPETITIVE; FERREDOXINS; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; IRON-SULFUR PROTEINS; KINETICS; MITOCHONDRIAL PROTEINS; MODELS, MOLECULAR; MUTATION, MISSENSE; NADP; OXIDATION-REDUCTION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; THIAZOLIDINEDIONES;

EID: 84859489753     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.319731     Document Type: Article

References (44)

1. Johnson, D. C., Dean, D. R., Smith, A. D., and Johnson, M. K. (2005) Structure, function, and formation of biological iron-sulfur clusters. Annu. Rev. Biochem. 74, 247-281 (Pubitemid 40995508)
2. Lill, R., and Mühlenhoff, U. (2008) Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu. Rev. Biochem. 77, 669-700
3. Lill, R. (2009) Function and biogenesis of iron-sulphur proteins. Nature 460, 831-838
4. Rouault, T. A., and Tong, W. H. (2008) Iron-sulfur cluster biogenesis and human disease. Trends Genet. 24, 398-407
5. Adinolfi, S., Iannuzzi, C., Prischi, F., Pastore, C., Iametti, S., Martin, S. R., Bonomi, F., and Pastore, A. (2009) Bacterial frataxin CyaY is the gate-keeper of iron-sulfur cluster formation catalyzed by IscS. Nat. Struct. Mol. Biol. 16, 390-396
6. Napier, I., Ponka, P., and Richardson, D. R. (2005) Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105, 1867-1874 (Pubitemid 40731766)
7. Camaschella, C., Campanella, A., De Falco, L., Boschetto, L., Merlini, R., Silvestri, L., Levi, S., and Iolascon, A. (2007) The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload. Blood 110, 1353-1358 (Pubitemid 47281436)
8. Sohn, Y. S., Breuer, W., Munnich, A., and Cabantchik, Z. I. (2008) Redistribution of accumulated cell iron: a modality of chelation with therapeutic implications. Blood 111, 1690-1699 (Pubitemid 351213461)
9. Hausmann, A., Samans, B., Lill, R., andMühlenhoff, U. (2008) Cellular and mitochondrial remodeling upon defects in iron-sulfur protein biogenesis. J. Biol. Chem. 283, 8318-8330
10. Hentze, M. W., Muckenthaler, M. U., and Andrews, N. C. (2004) Balancing acts: molecular control of mammalian iron metabolism. Cell 117, 285-297 (Pubitemid 38534536)
11. Hansen, T. M., and Nagley, P. (2003) AIF: a multifunctional cog in the life and death machine. Sci. STKE 2003, PE31
12. Cusimano, E. M., Knight, A. R., Slusser, J. G., Clancy, R. L., and Pierce, J. D. (2009) Mitochondria: the hemi of the cell. Adv. Emerg. Nurs. J. 31, 54-62
13. Abdul-Ghani, M. A., and DeFronzo, R. A. (2008) Mitochondrial dysfunction, insulin resistance, and type 2 diabetes mellitus. Curr. Diab. Rep. 8, 173-178
14. Lowell, B. B., and Shulman, G. I. (2005) Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387 (Pubitemid 40139974)
15. Saxena, R., de Bakker, P. I., Singer, K., Mootha, V., Burtt, N., Hirschhorn, J. N., Gaudet, D., Isomaa, B., Daly, M. J., Groop, L., Ardlie, K. G., and Altshuler, D. (2006) Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am. J. Hum. Genet. 79, 54-61 (Pubitemid 43927376)
16. Colca, J. R., McDonald, W. G., Waldon, D. J., Leone, J. W., Lull, J. M., Bannow, C. A., Lund, E. T., and Mathews, W. R. (2004) Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe. Am. J. Physiol. Endocrinol. Metab. 286, E252-260 (Pubitemid 38140317)
17. Colca, J. R., and Kletzien, R. F. (2006) What has prevented the expansion of insulin sensitisers? Expert Opin. Investig. Drugs 15, 205-210 (Pubitemid 43338142)
18. Hofmann, C. A., and Colca, J. R. (1992) New oral thiazolidinedione antidiabetic agents act as insulin sensitizers. Diabetes Care 8, 1075-1078
19. Pollak, N., Dölle, C., and Ziegler, M. (2007) The power to reduce: pyridine nucleotides-small molecules with a multitude of functions. Biochem. J. 402, 205-218 (Pubitemid 46383418)
20. Paddock, M. L., Wiley, S. E., Axelrod, H. L., Cohen, A. E., Roy, M., Abresch, E. C., Capraro, D., Murphy, A. N., Nechushtai, R., Dixon, J. E., and Jennings, P. A. (2007) MitoNEET is a uniquely folded 2Fe 2S outer mitochondrial membrane protein stabilized by pioglitazone. Proc. Natl. Acad. Sci. U.S.A. 104, 14342-14347 (Pubitemid 350003263)
21. Lin, J., Zhou, T., Ye, K., and Wang, J. (2007) Crystal structure of human mitoNEET reveals distinct groups of iron sulfur proteins. Proc. Natl. Acad. Sci. U.S.A. 104, 14640-14645 (Pubitemid 350003197)
22. Hou, X., Liu, R., Ross, S., Smart, E. J., Zhu, H., and Gong, W. (2007) Crystallographic studies of human MitoNEET. J. Biol. Chem. 282, 33242-33246 (Pubitemid 350159495)
23. Wiley, S. E., Paddock, M. L., Abresch, E. C., Gross, L., van der Geer, P., Nechushtai, R., Murphy, A. N., Jennings, P. A., and Dixon, J. E. (2007) The outer mitochondrial membrane protein mitoNEET contains a novel re-dox-active 2Fe-2S cluster. J. Biol. Chem. 282, 23745-23749 (Pubitemid 47327996)
24. Bak, D. W., Zuris, J. A., Paddock, M. L., Jennings, P. A., and Elliott, S. J. (2009) Redox characterization of the FeS protein MitoNEET and impact of thiazolidinedione drug binding. Biochemistry 48, 10193-10195
25. Zuris, J. A., Harir, Y., Conlan, A. R., Shvartsman, M., Michaeli, D., Tamir, S., Paddock, M. L., Onuchic, J. N., Mittler, R., Cabantchik, Z. I., Jennings, P. A., and Nechushtai, R. (2011) Facile transfer of [2Fe-2S] clusters from the diabetes drug target mitoNEET to an apo-acceptor protein. Proc. Natl. Acad. Sci. U.S.A. 108, 13047-13052
26. Zhou, T., Lin, J., Feng, Y., and Wang, J. (2010) Binding of reduced nicotinamide adenine dinucleotide phosphate destabilizes the iron - sulfur clusters of human mitoNEET. Biochemistry 49, 9604-9612
27. 2+ cluster transfer to an apoferredoxin target. Biochemistry 42, 5784-5791
28. Dutton, P. L. (1978) Redox potentiometry: determination of midpoint potentials of oxidation-reduction components of biological electrontransfer systems. Methods Enzymol. 54, 411-435
29. Zuris, J. A., Halim, D. A., Conlan, A. R., Abresch, E. C., Nechushtai, R., Paddock, M. L., and Jennings, P. A. (2010) Engineering the redox potential over a wide range within a new class of FeS proteins. J. Am. Chem. Soc. 132, 13120-13122
30. Albe, K. R., Butler, M. H., and Wright, B. E. (1990) Cellular concentrations of enzymes and their substrates. J. Theor. Biol. 143, 163-195 (Pubitemid 20141560)
31. Andersen, K. B., and von Meyenburg, K. (1977) Charges of nicotinamide adenine nucleotides and adenylate energy charge as regulatory parameters of the metabolism in Escherichia coli. J. Biol. Chem. 252, 4151-4156 (Pubitemid 8114436)
32. Dicus, M. M., Conlan, A., Nechushtai, R., Jennings, P. A., Paddock, M. L., Britt, R. D., and Stoll, S. (2010) Binding of histidine in the (Cys)3(His)1-coordinated [2Fe-2S] cluster of human mitoNEET. J. Am. Chem. Soc. 132, 2037-2049
33. Baxter, E. L., Jennings, P. A., and Onuchic, J. N. (2011) Interdomain communication revealed in the diabetes drug target mitoNEET. Proc. Natl. Acad. Sci. U.S.A. 108, 5266-5271
34. Tirrell, T. F., Paddock, M. L., Conlan, A. R., Smoll, E. J., Jr., Nechushtai, R., Jennings, P. A., and Kim, J. E. (2009) Resonance Raman studies of the (His)(Cys)3 2Fe-2S cluster of MitoNEET: comparison to the (Cys)4 mutant and implications of the effects of pH on the labile metal center. Biochemistry 48, 4747-4752
35. Conlan, A. R., Paddock, M. L., Homer, C., Axelrod, H. L., Cohen, A. E., Abresch, E. C., Zuris, J. A., Nechushtai, R., and Jennings, P. A. (2011) Mutation of the His ligand in mitoNEET stabilizes the 2Fe-2S cluster despite conformational heterogeneity in the ligand environment. Acta Crystallogr. D Biol. Crystallogr. 67, 516-523
36. Martinovich, G. G., Cherenkevich, S. N., and Sauer, H. (2005) Intracellular redox state: towards quantitative description. Eur. Biophys. J. 34, 937-942 (Pubitemid 41428190)
37. Hernandez, C., Genesca, J., Ignasi Esteban, J., Garcia, L., and Simo, R. (2000) Relationship between iron stores and diabetes mellitus in patients infected by hepatitis C virus: a case-control study. Med. Clin. 115, 21-22
38. Jiang, R., Manson, J. E., Meigs, J. B., Ma, J., Rifai, N., and Hu, F. B. (2004) Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291, 711-717 (Pubitemid 38543791)
39. Opara, E. C. (2004) Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control. J. Investig. Med. 52, 19-23
40. Valko, M., Morris, H., and Cronin, M. T. (2005) Metals, toxicity and oxidative stress. Curr. Med. Chem. 12, 1161-1208 (Pubitemid 40655271)
41. Wolff, S. P. (1993) Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br. Med. Bull. 49, 642-652
42. Chen, Y. F., Wu, C. Y., Kirby, R., Kao, C. H., and Tsai, T. F. (2010)Arole for the CISD2 gene in lifespan control and human disease. Ann. N.Y. Acad. Sci. 1201, 58-64
43. Amr, S., Heisey, C., Zhang, M., Xia, X. J., Shows, K. H., Ajlouni, K., Pandya, A., Satin, L. S., El-Shanti, H., and Shiang, R. (2007) A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2. Am. J. Hum. Genet. 81, 673-683 (Pubitemid 47596537)
44. Chang, N. C., Nguyen, M., Germain, M., and Shore, G. C. (2010) Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1. EMBO J. 29, 606-618